Kentucky 2022 Regular Session

Kentucky House Bill HB58

Introduced
1/4/22  

Caption

AN ACT relating to chronic pain treatments.

Impact

The bill would lead to an enhancement of healthcare coverage for chronic pain treatments across the state, filling gaps that previously existed for patients seeking alternative therapies. The legislation is seen as a proactive step towards addressing the opioid crisis by encouraging individuals to consider non-opioid treatment options for chronic pain before resorting to prescription medications. This could lead to a paradigm shift in how chronic pain is managed within the healthcare system, focusing more on a holistic approach to patient care.

Summary

House Bill 58 focuses on chronic pain treatments, mandating health benefit plans to cover up to twenty visits for various therapies aimed at treating chronic pain. These treatments may include acupuncture, physical therapy, massage therapy, occupational therapy, and other practices deemed relevant by licensed professionals. One of the significant provisions of this bill is that patients are allowed to seek these services without prior referrals from healthcare providers, thus simplifying access to alternative therapies for chronic pain management.

Sentiment

Overall sentiment around HB58 appears to be cautiously optimistic, with strong support from advocates for alternative medicine and patient rights. Proponents argue that this bill is a necessary development in the fight against opioid addiction, emphasizing preventive care and chronic pain management without the need for highly controlled substances. However, there are concerns from some healthcare practitioners about the potential implications on prescription practices and the possible increase in demand for these treatments, which they fear could overwhelm available resources.

Contention

Notable points of contention revolve around the requirement that alternative treatments be made readily accessible without prior consultations with medical doctors, which some practitioners view as a risk to patient safety. Additionally, the financial implications regarding insurance reimbursement for these treatments may trigger concerns over affordability and the sustainability of coverage, especially in a state where healthcare budgets are continually being scrutinized.

Companion Bills

No companion bills found.

Similar Bills

IN HB1462

Health matters.

KY HB321

AN ACT relating to health benefit coverage of chronic pain treatments.

KY HB67

AN ACT relating to health benefit coverage of chronic pain treatments.

NJ A2191

Increases amount allowed in initial prescription for opioid drugs in cases of acute pain.

KY HB506

AN ACT relating to chronic pain treatments.

NJ A3342

Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven day supply, except in certain circumstances.

CT SB00511

An Act Concerning Opioids.

IN HB1445

Audit of Medicaid program prescription drug costs.